Stock Analysis
Canopy Growth Corporation Common SharesCGC
Sector: Healthcare · Industry: Medicinal Chemicals & Botanical Products
AnalystsBuy12 analystsPrice is 0% of the way from the year's low to its high.
Cash covers 168% of debt · FY 2026.
PMP Verdict
Weak fundamentals
Risks
- Growth0
- Profitability0
Weak fundamentals — valuation is the only support.
Market context
-3.1% today· Z 0.5σ
What's happening with CGC
Profile
growth, profitability, moat, earnings quality and valuation lag behind.
How is each axis scored?
- Valuation45/100 · Weak
- P/E vs own history (n/a)10/25
- FCF yield (-28.7%)0/25
- P/S (1.1x)25/25
- EV/EBIT (n/a)10/25
- Growth0/100 · Weak
- Revenue CAGR (-14.0%)0/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (n/a)0/25
- Profitability0/100 · Weak
- ROIC (-12.1%)0/25
- ROE (-46.8%)0/25
- Net margin (-117.3%)0/25
- Operating margin (-30.2%)0/25
- Financial Health53/100 · Moderate
- Altman Z (-13.46)3/25
- Current ratio (3.34)25/25
- Interest coverage (-12.1x)0/25
- Net cash / debt (Net cash)25/25
- Quality35/100 · Weak
- Piotroski F (4/9)10/25
- Beneish M (-2.52)25/25
- FCF conversion (n/a)0/25
- Margin stability (σ 389.0%)0/25
- Moat0/100 · Weak
- ROIC >12% years (0/6 yrs)0/25
- Median gross margin (2.2%)0/25
- FCF-positive years (0/6 yrs)0/25
- Worst-year net margin (worst -813.6%)0/25
Risk Flags
- ⚠Altman Z -13.5 — distress-zone balance sheet
- ⚠Negative FCF margin (-0.3%) — burning cash
- ⚠6 loss-making years in recent history
- ⚠Interest coverage -12.1× — thin debt cushion
- ⚠Revenue shrinking 14.0%/yr
About Canopy Growth Corporation Common Shares
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. Show more
The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Headquarters: SMITH FALLS, A6 · Employees: 1,128 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
45D+P/E (TTM)—
Price / TTM EPS (own statements)
P/FCF—
Price / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield-28.7%D
Grade D: NegativeTTM (OCF − CapEx) / Market Cap — vs own 5Y history: -623.9%–-8.8% · 80th pct
P/S (TTM)1.08xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.2x–11.0x · 55th pct
EV/EBITDA90.5xD
Grade D: ExpensiveEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales1.4xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E—
Price / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio0.43xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio—
Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
0EROIC-12.1%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE-46.8%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA-21.5%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin-117.3%D
Grade D: LowNet Income / Revenue
Operating Margin-30.2%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin25.8%D
Grade D: LowGross Profit / Revenue
FCF Margin-30.9%D
Grade D: LowFCF / Revenue
True FCF Margin-28.2%D
Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
0ERevenue CAGR-14.0%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth—
Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue-2.7%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
53CAltman Z-Score-13.46D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio3.34xA
Grade A: HighCurrent Assets/Liabilities
Quick Ratio2.35xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage-12.1xD
Grade D: RiskyEBIT/Interest. >10 Strong
Debt RepaymentNet CashA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT1.8xA
Grade A: LowLeverage. <2x Low, >4x High
Debt/Equity0.31xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt1.68xA
Grade A: CoveredCash covers how much of total debt. >1 = could repay all debt from cash
Quality
35DPiotroski F-Score4/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.52A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability389.0%D
Grade D: VolatileEBIT margin std deviation. Lower = stable
Capex / Revenue2.7%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.27xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Stewart Thomas Carlton Filed | Stewart Thomas Carlton | SellOpen market sale | -25755 | |
Gedeon Christelle Filed | Gedeon Christelle | SellOpen market sale | -13344 | |
Stewart Thomas Carlton Filed | Stewart Thomas Carlton | SellOpen market sale | -2231 | |
Lazzarato David Angelo Filed | Lazzarato David Angelo | Grant / award | +162.5K | |
Yanofsky Theresa Filed | Yanofsky Theresa | Grant / award | +108.3K |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Stewart Thomas Carlton Filed | Stewart Thomas Carlton | Grant / award | +463.3K | |
Stewart Thomas Carlton Filed | Stewart Thomas Carlton | SellOpen market sale | -9285 | |
Stewart Thomas Carlton Filed | Stewart Thomas Carlton | Grant / award | +379.0K |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
0EROIC >12% Years0/6 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)2.2%D
Grade D: WeakMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years0/6 yrsD
Grade D: WeakShare of completed fiscal years with positive free cash flow
Net Margin Floor-813.6%D
Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)—
TTM net income per share (Finnhub fallback)
Cash / Share$0.80
Cash & short-term investments per share (Finnhub)
Book Value / Share$1.63
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$217.12M
Total debt obligations (short + long term)
Cash & Equiv.$364.68M
Cash and short-term investments
Net Debt$-147.56MA
Grade A: Net CashTotal Debt minus Cash. Negative = Net Cash position
Total Equity$697.59M
Shareholders' equity (book value)
Asset / Liability2.66xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$300.00M
Current Market Capitalization
Beta1.87D
Grade D: High volatilityPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Canopy Growth Corporation Common Shares (CGC)
CGC is down 3.06% at the last close. Piotroski F-Score of 4/9 indicates mixed fundamentals for Canopy Growth Corporation Common Shares. Altman Z-Score of -13.46 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of -2.52 suggests a low likelihood of earnings manipulation. Revenue has been contracting (CAGR ≈ -14%), which weighs on the growth outlook.
- Free-cash-flow margin is negative (-31%) — the business currently burns cash.
- Company is effectively debt-free after netting cash.
- Interest coverage of -12.1× leaves little room for earnings shocks.
- Canopy Growth Corporation Common Shares posted a net loss in 6 of 6 available completed fiscal years (2020–2026).
See how CGC ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all CGC moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 14 | Regular | 0.71 | -6.49% | -2.17 |
| Oct 14 | After-hours | 0.72 | -6.07% | -2.00 |
| Oct 12 | Regular | 0.76 | -8.08% | -3.88 |
| Oct 12 | After-hours | 0.76 | -7.92% | -3.80 |
| Oct 8 | Regular | 0.84 | -4.20% | -2.13 |
Frequently Asked Questions about CGC
What is the current Canopy Growth Corporation Common Shares (CGC) stock price?
CGC is trading at $0.71 at the last market close, down 3.06% on the session. PreMarketPrice tracks CGC pre-market, intraday and after-hours prices.
Is CGC stock a buy right now?
PreMarketPrice's quantitative model rates Canopy Growth Corporation Common Shares's financial health at 53/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is CGC stock overvalued?
Canopy Growth Corporation Common Shares trades at a trailing P/E of n/a and our valuation score rates it 45/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Canopy Growth Corporation Common Shares report earnings?
No confirmed earnings date is currently scheduled for CGC. The Earnings section lists recent reports and updates as dates are announced.
What sector does Canopy Growth Corporation Common Shares operate in?
Canopy Growth Corporation Common Shares operates in the Healthcare sector, within the Medicinal Chemicals & Botanical Products industry. The Related Stocks section lists sector peers for comparison.
What does Canopy Growth Corporation Common Shares do?
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada.
About Canopy Growth Corporation Common Shares (CGC) Stock
Canopy Growth Corporation Common Shares (CGC) is a US-listed stock operating in the Healthcare sector, specifically the Medicinal Chemicals & Botanical Products industry. As of the latest update, Canopy Growth Corporation Common Shares is trading at $0.71, down 3.06% on the day with a market capitalization of $300 million. The financial health score for CGC is 53/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for CGC stock.
CGC Stock Analysis & Key Metrics
On PreMarketPrice, you can track Canopy Growth Corporation Common Shares (CGC) across multiple dimensions:
- Pre-market price & movement: Real-time CGC stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for CGC with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Canopy Growth Corporation Common Shares across multiple reporting periods.
- Financial health score: A composite score of 53/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for CGC.
- Sector peers: Compare CGC against 4 other healthcare stocks on key financial metrics.
Is CGC a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Canopy Growth Corporation Common Shares (CGC) as an investment. The financial health score of 53/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Canopy Growth Corporation Common Shares (CGC) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.